Work

Characterization of Mutants and Splice Variants of Hepatitis B Virus Isolated From South African Black Hepatocellular Carcinoma Patients.

Year: 2010
Type: dissertation
Abstract: Hepatitis B virus (HBV) infection is endemic in Africa. As many as 98% of black \nAfricans are infected during their lives and about 10% (65 million) have chronic \nHBV infection, which is the cause of 70-80% of all hepatocellular carcinoma (HCC) \ncases. Despite this high prevalence of HBV and the high incidence of HCC in \nAfrica, relatively few complete HBV genomes from African HCC cases have been \ndeposited in international data bases. In order to gain a clearer understanding of \nthe role of genetic variants and mutants in the development of HCC, the complete \ngenomes of HBV isolated from southern African HCC patients were amplified and \nmolecularly characterized. HBV DNA was extracted from the serum forty HBsAgpositive \nHCC patients. Twenty six complete genomes were successfully amplified, \ncloned and sequenced from nine HCC patients. \nPhylogenetic analyses of the complete genomes and the individual open reading \nframes of HBV isolates from the HCC patients, led to the classification of all the \nisolates within subgenotype A1. No isolates belonging to subgenotype A2 and \ngenotype D were identified, even though these genotypes/subgenotypes have \nbeen shown to circulate in South Africa. Three patients contained the uncommon \ncombination of serological subtype ayw1 in the subgenotype A1 strain. This \ncombination has been found previously in South Africa and the Phillipines. \nSeventy-eight percent of the patients carried HBV strains with the double basic \ncore promoter (BCP) mutation (1762T/1764A), previously shown to reduce HBeAg \nexpression. Furthermore, complete genome sequence analysis has revealed a \ncomplex combination of mutations, which include at least three or five of these \nresidues 1753C1762T1764A1766T1768A1809T1812T occurring as the dominant \nHBV strains isolated from 5/9 HCC patients. These mutations have previously \nbeen shown to regulate gene expression at various levels, to enhance viral \nreplication and simultaneously decrease HBeAg expression. \nAll five HBV genomes isolated from one patient contained novel complex BCP \nrearrangements, which introduced 2 HNF1 and 1 putative HNF3 transcription \nfactor binding sites. These mutations can enhance viral replication and \nsimultaneously abolish HBeAg expression at a transcriptional level. Furthermore, \ntruncated core proteins would be expressed from 4/5 isolates and none would \nexpress wild-type HBx. Several mutations were identified in the pre-S/S genes of \n2/5 isolates, which would result in the expression of novel 3’ truncated medium \nsurface proteins (MHBst) and large surface proteins (LHBst). The majority of the \nmutations would contribute to hepatocyte pathogenesis and transformation by \nactivating cell proliferating pathways. \nTwo patients also contained rare HBV variants not previously identified in HBV \nstrains from southern Africa. These included an HBV splice variant and a poly (dA) \nvariant from patient 10 and patient 6, respectively. These variants occurred in \ncombination with other isolates within the respective patients. \nThe envelope genes were characterised in a total of 18 HCC patients, the pre-S \ngene of HBV contained deletions in 72% of the patients. Deletions across pre- \nS1/pre-S2, pre-S2 initiation codon mutations with internal deletions, and S gene \nnonsense mutations were prevalent. Mutated envelope proteins have been shown \nto accumulate within the hepatocyte endoplasmic reticulum (ER) and are a \ncharacteristic histopathological hallmark of HCC known as ground glass \nhepatocytes. HBV induced ER stress has been shown to dysregulate several cell \ncycle regulatory pathways, which contribute to HCC. \nIn addition several novel LHBst and MHBst have been described. These potential \ntransactivators require further investigation. The HBV mutations described in this \nstudy have been associated with increased risk for HCC. \nDespite the obvious heterogeneity HBV displays within and between patients, \nthere are common characteristics shared between the HBV variants which emerge \nduring the development of HCC. These include the BCP and pre-C \n(1753C1762T1764A1766T1768A1809T1812T) mutations and the pre-S/S \nmutations. These mutations are able to affect HBV replication and gene \nexpression, and may work synergistically to promote liver dysfunction and HCC.
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: green
OpenAlex ID: W11603155
Cites: 364
Cited by: 2
Related to: 10